Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yunshuo Chen"'
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-14 (2023)
Abstract Background DNA methyltransferase 3A (DNMT3A) is frequently mutated in acute myeloid leukemia (AML) with Arg882His (R882H) as the hotspot mutation. It has been reported that DNMT3A mutation plays a key role in leukemogenesis through hypomethy
Externí odkaz:
https://doaj.org/article/16b728dabd6d439daeab0996e8f723da
Autor:
Xiao Wang, Xuejiao Yang, Yueping Wang, Yunshuo Chen, Ying Yang, Siqi Shang, Wenbo Wang, Yueying Wang
Publikováno v:
Cancers, Vol 15, Iss 1, p 251 (2022)
Immunotherapies based on immune checkpoint blockade, neoantigen-reactive tumor-infiltrating lymphocytes and T cell receptor-engineered T cells (TCR-T) have achieved favorable clinical outcomes in tumor treatment. However, sustained immune response an
Externí odkaz:
https://doaj.org/article/44b58688ff174c748b5ec1f2e3bebce0
Autor:
Qianhui Ren, Jing Pan, Yunshuo Chen, Zhecheng Shen, Zhao Yang, Kubin Kwon, Ying Guo, Yueying Wang, Fang Ji
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Introduction: Melatonin, an endogenous neurohormone, modulates the biological circadian rhythms of vertebrates. It functions have been reported in previous stomatological studies as anti-inflammation, antioxidant, osseointegration of dental implants
Externí odkaz:
https://doaj.org/article/f990e4f9b4514ab8b6dd88fa9e5d4a08
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Severe cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) strongly hampered the broad clinical applicability of chimeric antigen receptor T cell (CAR-T) therapy. Vascular endothelial activation has been
Externí odkaz:
https://doaj.org/article/cf79f16f11834bd09f4ed5d4d74f935a
Publikováno v:
Investigational New Drugs. 41:220-225
Chimeric antigen receptor T (CAR-T) cell therapy has become a research hotspot in the field of hematological malignancies. However, CAR-T cell therapy can lead to immunotherapy-associated side effects including cytokine release syndrome and neurotoxi
DNMT3A-R882H mutation is a frequent epigenetic mutation in acute myeloid leukemia (AML)-M4 and M5, participating in the regulation of cell growth and differentiation by blocking the binding of transcription factor complexes to DNA. However, effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebc67c8f577879dc4221298b4fc00c56
https://doi.org/10.21203/rs.3.rs-2352928/v1
https://doi.org/10.21203/rs.3.rs-2352928/v1
Autor:
Yunshuo Chen, Fanqiang Fu
Publikováno v:
Journal of Applied Mathematics and Physics. 10:2708-2719
Publikováno v:
Frontiers in Immunology
Severe cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) strongly hampered the broad clinical applicability of chimeric antigen receptor T cell (CAR-T) therapy. Vascular endothelial activation has been